mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.048 |
0.4 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |